Moderna Inc (MRNA)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 8,099,000 | 10,325,000 | 13,431,000 | 16,071,000 | 6,298,000 |
| Total current liabilities | US$ in thousands | 2,206,000 | 3,015,000 | 4,923,000 | 9,128,000 | 4,389,000 |
| Current ratio | 3.67 | 3.42 | 2.73 | 1.76 | 1.43 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $8,099,000K ÷ $2,206,000K
= 3.67
The current ratio of Moderna Inc has shown a positive trend over the past five years, indicating the company's improving short-term liquidity position. The ratio has increased steadily from 1.43 as of December 31, 2020, to 3.67 as of December 31, 2024. This suggests that Moderna Inc has been able to strengthen its ability to meet its short-term obligations with its current assets over the years, reflecting potentially efficient management of working capital and financial resources. The current ratio exceeding 1 indicates that the company has more than enough current assets to cover its current liabilities, providing a favorable indication of financial health and stability.
Peer comparison
Dec 31, 2024